Pre-exposure prophylaxis against HIV infection

Q4 Medicine

Ugeskrift for laeger Pub Date : 2024-05-06 DOI:10.61409/v10230672

F. Engsig, G. Kronborg

引用次数: 0

Abstract

Pre-exposure prophylaxis (PrEP) decreases the risk for HIV transmission in high-risk populations. PrEP has been available in Denmark since 2019 and consists of antiretroviral drugs in a combination tablet taken daily or on demand. The effect of this prophylaxis in Denmark is summarized in the review. PrEP is indicated in men and transgender persons with unprotected anal intercourse with multiple male partners in the latest 12 weeks or recent diagnoses of syphilis, chlamydia, or gonorrhoea. PrEP is provided by infectious disease specialists. Continued implementation could significantly reduce HIV transmission and potentially end the epidemic in Denmark.

查看原文本刊更多论文

接触前预防艾滋病毒感染

暴露前预防（PrEP）可降低高危人群的艾滋病毒传播风险。PrEP 自 2019 年起在丹麦开始提供，由每天服用或按需服用的抗逆转录病毒药物复合片剂组成。本综述总结了这种预防措施在丹麦的效果。PrEP 适用于在最近 12 周内与多个男性伴侣进行无保护肛交或最近诊断出梅毒、衣原体或淋病的男性和变性人。PrEP 由传染病专家提供。继续实施可大大减少艾滋病毒的传播，并有可能在丹麦终结这一流行病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ugeskrift for laeger Medicine-Medicine (all)

CiteScore

0.20

自引率

0.00%

发文量

345

期刊介绍： The Ulster Medical Journal is an international general medical journal with contributions on all areas of medical and surgical specialties relevant to a general medical readership. It retains a focus on material relevant to the health of the Northern Ireland population. The Honorary Editor would welcome offers of papers for publication. Prospective authors are invited to read the notice to contributors.